Legend Biotech (LEGN) Interest Expenses (2019 - 2026)
Legend Biotech's (LEGN) quarterly Interest Expenses came in at $5.5 million in Q1 2026, up 7.84% YoY from $5.1 million in Q1 2025, and up 200.0% on a QoQ basis from -$5.5 million in Q4 2025.
Legend Biotech (LEGN) Interest Expenses (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Interest Expenses data on file, last reported at $5.5 million in Q1 2026.
- Quarterly Interest Expenses rose 7.84% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.9 million (up 2.07% YoY) and the FY2025 annual result came in at -$21.4 million, down 199.01% from the prior year.
- Interest Expenses grew to $5.5 million in Q1 2026, from -$5.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $15.4 million in Q2 2023 to a low of -$26.3 million in Q3 2023.
- A 5-year average of -$1.9 million and a median of -$4.9 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 4043.81% — and 2024, when it plunged 89247.08%.
- Tracing LEGN's Interest Expenses over 5 years: stood at -$4.9 million in 2022, then surged by 99.88% to -$5820.0 in 2023, then sank by 89247.08% to -$5.2 million in 2024, then retreated by 5.77% to -$5.5 million in 2025, then surged by 200.0% to $5.5 million in 2026.
- The last three Interest Expenses figures came in at $5.5 million (Q1 2026), -$5.5 million (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 5.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.80 Mn |
| Jun 30, 2026 | 5.80 Mn |
| Mar 31, 2026 | 5.50 Mn |
| Mar 31, 2026 | 5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | 5.10 Mn |
| Mar 31, 2025 | 5.10 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Mar 31, 2024 | 5.48 Mn |